查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1843657

2025年全球医疗诊断人工智慧市场报告

Artificial Intelligence in Healthcare Diagnosis Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，人工智慧在医疗诊断领域的市场规模呈指数级增长，从2024年的231.8亿美元增长到2025年的330.3亿美元，复合年增长率达42.5%。预测期内的成长归因于医学影像技术的进步、资料可近性和数数位化、临床工作流程的最佳化、研发投资以及医疗专业人员的短缺。

预计未来几年，人工智慧在医疗诊断领域的市场规模将呈指数级增长，到2029年将达到1534亿美元，年复合成长率（CAGR）高达46.8%。预测期内的成长主要得益于人工智慧赋能的精准医疗、与电子健康记录的整合、医学影像分析的扩展、穿戴式健康技术的兴起、监管支持以及标准化。预测期内的关键趋势包括：可解释人工智慧在医疗保健领域的应用、人工智慧驱动的早期疾病检测、远端保健整合、人工智慧在病理学和组织病理学领域的应用，以及人工智慧赋能的照护现场诊断。

人工智慧（AI）在医疗诊断领域的应用，是指将机器学习和深度学习演算法等人工智慧技术应用于疾病诊断。人工智慧能够快速评估包括实验室检测结果、医疗记录和基因资讯在内的各种数据，与传统的人工诊断方法相比，能够为医疗专业人员提供更快捷的诊断。

人工智慧在医疗诊断领域的主要组成部分包括软体、服务和硬体。软体是程式、资料和指令的集合，旨在在电脑和电子设备上执行特定任务。这些组成部分应用于多种医学诊断，包括心臟病学、肿瘤学、病理学、放射学、胸腔肺科和神经病学。诊断方式包括磁振造影造影 (MRI)、电脑断层扫描 (CT)、X光和超音波，可用于体内和体外诊断。最终用户包括医院、影像诊断中心和诊断实验室。

美国2025年关税上调及其引发的贸易紧张局势正对资讯科技产业产生重大影响，尤其是在硬体製造、资料基础设施和软体部署方面。进口半导体、电路基板和网路设备的关税提高，并推高了高科技公司、云端服务供应商和资料中心的生产和营运成本。在全球范围内采购笔记型电脑、伺服器和消费电子产品零件的公司面临更长的前置作业时间週期和价格压力。同时，对专用软体征收的关税以及主要国际市场的报復性措施扰乱了全球IT供应链，并降低了海外对美国製造技术的需求。为了应对这些挑战，该行业正在加大对国内晶片生产的投资，扩大供应商网络，并利用人工智慧驱动的自动化技术来增强韧性并更有效地控製成本。

这份《医疗诊断人工智慧市场研究报告》是商业研究公司最新报告系列的一部分，提供医疗诊断人工智慧市场统计数据，包括全球市场规模、区域份额、竞争对手及其市场份额、详细的市场细分、市场趋势和商业机会。本市场研究报告对该行业的现状和未来发展趋势进行了深入分析，为您提供所需的一切全面观点。

未来五年46.8%的预测成长率较我们先前对该市场的预测略微下降了0.2%。这一下降主要归因于美国与其他国家之间的关税影响。关税将增加采购和维护人工智慧影像处理和分析平台的维修成本，这可能会影响美国诊所的诊断准确性。此外，由于相互关税以及贸易紧张局势和限制措施升级对全球经济和贸易造成的负面影响，其影响范围将更加广泛。

人工智慧（AI）在医疗诊断领域的市场成长预期主要受慢性病盛行率上升的驱动。慢性病具有长期进展和间歇性持续的特点，并有望受益于人工智慧在医疗诊断领域的变革性影响。这项技术可望显着改善疾病管理、诊断和资源利用，从而降低成本。人工智慧可以增强医疗专业人员的决策能力，识别高风险患者，并帮助他们提供更个人化的照护。例如，世界卫生组织（WHO）在2022年9月报告称，每年将有4,100万人死亡，其中74%的死亡将归因于非传染性疾病（NCD）或慢性病。这些死亡包括1,790万人死于心血管疾病，930万人死于癌症，410万人死于慢性呼吸道疾病，以及200万人死于糖尿病。因此，慢性病盛行率的上升是推动人工智慧在医疗诊断市场成长的主要因素。

预计未来远距远端医疗的日益普及将推动人工智慧在医疗诊断市场的发展。远距远端医疗是指利用视讯会议、语音通话和其他数位通讯工具等通讯技术远端提供医疗保健服务。远端医疗的兴起正在推动医疗诊断领域对人工智慧的需求。人工智慧工具可以帮助医疗服务提供者根据患者报告的症状和数据进行远距离诊断。例如，2023年4月，美国非营利组织FAIR Health（致力于提高医疗成本和保险资讯的透明度）报告称，全美远端医疗使用量年增7.3%，其中纯音频远距远端医疗服务在农村地区的普及率高于都市区。因此，远距远端医疗领域的不断扩展正在推动人工智慧在医疗诊断市场的发展。

技术进步已成为医疗诊断人工智慧市场中一个引人注目的趋势，并且正在迅速发展。该市场的主要企业正积极致力于开发创新技术以保持竞争力。例如，2023年3月，总部位于法国的生物技术公司Genomic Vision推出了FiberSmart，这是一款由人工智慧驱动的软体，旨在自动检测和量化梳状DNA（去氧核糖核酸）分子上的萤光讯号。 FiberSmart拥有使用者友善的介面，能够快速分析DNA复製讯号并提取描述复製动力学的关键参数。凭藉先进的人工智慧技术，FiberSmart超越了Genomic Vision现有的软体解决方案，将DNA复製动力学的可视化、检测和评估的准确性提高了三倍，同时速度提高了十倍。该软体符合人体工学的设计提升了用户体验，使用户能够快速分析DNA复製讯号并推导出解释复製动力学的关键变数。

医疗诊断人工智慧市场的关键参与者正致力于开发创新解决方案，重点关注基于人工智慧的疾病检测。这涉及利用人工智慧技术分析医疗数据，例如影像、患者记录和诊断测试，以识别和检测各种疾病和健康状况。例如，2023年5月，总部位于美国的下一代创投工作室Aegis Ventures LLC与美国医疗科技公司Northwell Holdings合作推出了「OptAIn」。 OptAIn利用便携式简易视网膜相机拍摄的眼部影像，其人工智慧不仅可以筛检眼部疾病，还可以辨识全身140多种其他疾病。其目标是在这些疾病的早期、最容易治疗的阶段进行检测。

2022年10月，美国临床诊断公司贝克曼库尔特诊断公司（Beckman Coulter Diagnostics）完成了对StoCastic LLC的收购，具体金额未揭露。 StoCastic的TriageGo将成为贝克曼库尔特人工智慧驱动的临床决策支援（CDS）产品组合的核心。这一新兴领域旨在透过向医生提供数据驱动的洞察并优化临床决策，从而提升患者护理水平。 StoCastic LLC是一家总部位于美国的人工智慧公司，专注于开发人工智慧工具，以帮助医疗服务提供者更准确、更有效率地进行疾病诊断。

人工智慧在医疗保健诊断市场的主要参与者包括强生私人有限公司、英特尔公司、国际商业机器公司、美敦力公司、英伟达公司、西门子医疗保健有限公司、皇家飞利浦公司、通用电气医疗集团、爱克发-吉华集团、GoogleDeepMind、Babylon Health、HeartFlow Inc、Corti 、Agidoc, Nidr. Inc.、Enlitic Inc.、NovaSignal Corp.、Cleerly Inc.、Butterfly Network Inc.、IBM Watson Health、Arterys Inc.、Zebra Medical Vision Inc.、Vuno Inc.、RiverAIn Technologies、CloudMedX Inc.和Neural Analytics Inc.。

2024年，北美是医疗保健诊断人工智慧市场最大的地区。医疗保健诊断人工智慧市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美以及中东和非洲。

医疗保健诊断人工智慧市场报告涵盖的国家包括澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、义大利、西班牙和加拿大。

医疗诊断领域的人工智慧（AI）市场由提供医学影像分析、基因分析、临床决策支援、风险预测和分层等服务的营业单位所获得的收入所构成。市场价值还包括服务供应商销售的或包含在其服务产品中的相关产品的价值。此外，医疗诊断领域的人工智慧（AI）市场还包括用于提供医疗诊断人工智慧服务的手术机器人和视觉工具的销售额。此市场价值为“出厂价”，即製造商或生产商销售给其他营业单位（包括下游製造商、经销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球人工智慧在医疗诊断中的应用：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球医疗诊断人工智慧市场：成长率分析
  • 全球医疗诊断人工智慧市场表现：规模与成长，2019-2024年
  • 全球医疗诊断人工智慧市场预测：规模与成长，2024-2029年，2034年
  • 全球医疗诊断人工智慧：潜在市场规模 (TAM)

第六章 市场细分

  • 全球医疗诊断人工智慧市场：按组件、效能和预测划分，2019-2024年、2024-2029年、2034年
  • 软体
  • 服务
  • 硬体
  • 全球医疗诊断人工智慧市场：依诊断类型、效能和预测划分，2019-2024年、2024-2029年、2034年
  • 心臟病学
  • 肿瘤学
  • 病理
  • 放射科
  • 胸部/肺部
  • 神经病学
  • 其他的
  • 全球医疗诊断人工智慧市场按模式、效能和预测划分，2019-2024年、2024-2029年、2034年
  • 磁振造影（MRI）
  • CT（电脑断层扫描）
  • X射线
  • 超音波
  • 全球医疗诊断人工智慧市场：按应用、效能和预测划分，2019-2024年、2024-2029年、2034年
  • 体内诊断
  • 体外诊断
  • 全球医疗诊断人工智慧市场（按最终用户、效能和预测划分，2019-2024年、2024-2029年、2034年）
  • 医院
  • 诊断影像中心
  • 诊断实验室
  • 其他的
  • 全球医疗诊断人工智慧市场：软体细分、按类型划分、实际结果和预测（2019-2024年、2024-2029年、2034年）
  • 诊断软体
  • 影像分析软体
  • 预测分析软体
  • 全球医疗诊断人工智慧市场：服务细分、按类型划分、实际结果和预测（2019-2024年、2024-2029年、2034年）
  • 咨询服务
  • 实施服务
  • 维护和支援服务
  • 全球医疗诊断人工智慧市场：硬体细分、类型、实际结果和预测（2019-2024年、2024-2029年、2034年）
  • 诊断影像设备
  • 人工智慧驱动的医疗设备
  • 资料储存和处理硬体

第七章 区域和国家分析

  • 全球医疗诊断人工智慧市场：按地区、绩效和预测划分，2019-2024年、2024-2029年、2034年
  • 全球医疗诊断人工智慧市场：国家、表现与预测，2019-2024年、2024-2029年、2034年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 人工智慧在医疗诊断市场的应用：竞争格局
  • 人工智慧在医疗诊断市场的应用：公司概况
    • Johnson and Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis
    • Intel Corporation Overview, Products and Services, Strategy and Financial Analysis
    • International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic Overview, Products and Services, Strategy and Financial Analysis
    • Nvidia Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Siemens Healthcare GmbH
  • Koninklijke Philips NV
  • GE Healthcare
  • Agfa-Gevaert Group
  • Google Deep Mind
  • Babylon Health
  • HeartFlow Inc.
  • Corti HQ
  • Aidoc
  • Aidoc Medical Ltd.
  • Imagen Technologies
  • AliveCor Inc.
  • Digital Diagnostics Inc.
  • Enlitic Inc.
  • NovaSignal Corp.

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年医疗诊断人工智慧市场：提供新机会的国家
  • 2029年医疗诊断人工智慧市场：新兴细分市场机会
  • 2029年医疗诊断人工智慧市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r24687u

Artificial intelligence (AI) in healthcare diagnosis involves the application of AI techniques, such as machine learning and deep learning algorithms, for the purpose of diagnosing medical conditions. The utilization of AI allows for the rapid evaluation of data, encompassing clinical trials, medical records, and genetic information, providing medical practitioners with a quicker diagnosis compared to traditional human methods.

The primary components incorporated in artificial intelligence in healthcare diagnosis consist of software, services, and hardware. Software is a compilation of programs, data, and instructions designed to execute specific tasks on a computer or electronic device. These components are utilized across various medical diagnoses, including cardiology, oncology, pathology, radiology, chest and lung, neurology, and others. The modalities involved comprise MRI (magnetic resonance imaging), CT (computed tomography), X-ray, and ultrasound, catering to applications in both in vivo and in vitro diagnostics. The end-users benefiting from these AI applications include hospitals, diagnostic imaging centers, diagnostic laboratories, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the ensuing trade tensions in spring 2025 are having a significant impact on the information technology sector, especially in hardware manufacturing, data infrastructure, and software deployment. Increased duties on imported semiconductors, circuit boards, and networking equipment have driven up production and operating costs for tech companies, cloud service providers, and data centers. Firms that depend on globally sourced components for laptops, servers, and consumer electronics are grappling with extended lead times and mounting pricing pressures. At the same time, tariffs on specialized software and retaliatory actions by key international markets have disrupted global IT supply chains and dampened foreign demand for U.S.-made technologies. In response, the sector is ramping up investments in domestic chip production, broadening its supplier network, and leveraging AI-powered automation to improve resilience and manage costs more effectively.

The artificial intelligence in healthcare diagnosis market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in healthcare diagnosis market statistics, including artificial intelligence in healthcare diagnosis industry global market size, regional shares, competitors with an artificial intelligence in healthcare diagnosis market share, detailed artificial intelligence in healthcare diagnosis market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in healthcare diagnosis industry. This artificial intelligence in healthcare diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence in healthcare diagnosis market size has grown exponentially in recent years. It will grow from $23.18 billion in 2024 to $33.03 billion in 2025 at a compound annual growth rate (CAGR) of 42.5%. The growth in the historic period can be attributed to advancements in medical imaging, data accessibility and digitization, clinical workflow optimization, research and development investments, shortage of healthcare professionals.

The artificial intelligence in healthcare diagnosis market size is expected to see exponential growth in the next few years. It will grow to $153.4 billion in 2029 at a compound annual growth rate (CAGR) of 46.8%. The growth in the forecast period can be attributed to ai-powered precision medicine, integration with electronic health records, expansion of medical imaging analysis, rise of wearable health tech, regulatory support and standards. Major trends in the forecast period include explainable ai in healthcare, ai-driven early disease detection, telehealth integration, ai in pathology and histopathology, ai-enabled point-of-care diagnostics.

The forecast of 46.8% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Diagnostic accuracy in U.S. clinics could be affected as tariffs make AI-supported imaging and analysis platforms more expensive to procure and maintain. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated growth in the artificial intelligence (AI) in healthcare diagnosis market is driven by the increasing incidence rate of chronic diseases. Chronic diseases, characterized by their long-term progression and intermittent persistence, are expected to benefit from the transformative impact of AI in healthcare diagnosis. This technology holds the potential for significant improvements in disease management, diagnosis, and resource utilization, leading to cost savings. AI can empower medical practitioners to enhance decision-making, identify patients at risk, and deliver more personalized care. For example, in September 2022, the World Health Organization reported 41 million deaths annually, with 74% attributed to non-communicable diseases (NCDs) or chronic diseases globally. These included 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Consequently, the rising incidence of chronic diseases is a key driver of the growth in the artificial intelligence in the healthcare diagnosis market.

The growing use of telemedicine is expected to drive the growth of artificial intelligence in the healthcare diagnosis market in the future. Telemedicine involves using telecommunications technologies, such as video conferencing, audio calls, and other digital communication tools, to deliver medical care and services remotely. The rise of telemedicine has led to increased demand for AI in healthcare diagnosis. AI tools can assist healthcare providers in making remote diagnoses based on patient-reported symptoms and data. For example, in April 2023, FAIR Health, a US-based nonprofit organization focused on promoting transparency in healthcare costs and insurance information, reported a 7.3% increase in national telehealth utilization compared to the previous year, with audio-only telehealth services being more prevalent in rural areas than in urban ones. Thus, the growing telemedicine landscape is driving the expansion of artificial intelligence in the healthcare diagnosis market.

Technological advancement stands out as a prominent trend gaining traction in the artificial intelligence in the healthcare diagnosis market. Leading companies in this market are actively focusing on the development of innovative technologies to maintain their competitive edge. For instance, in March 2023, Genomic Vision, a biotechnology company based in France, unveiled FiberSmart, an AI-powered software designed to automate the detection and quantification of fluorescent signals on combed DNA (Deoxyribonucleic acid) molecules. Boasting a user-friendly interface, FiberSmart facilitates rapid analysis of DNA replication signals, extracting crucial parameters that describe replication kinetics. Employing advanced AI techniques, FiberSmart surpasses Genomic Vision's existing software solutions, offering up to three times more accurate visualization, detection, and evaluation of DNA replication kinetics, all achieved up to ten times faster. The software's ergonomic design enhances user convenience, enabling swift analysis of DNA replication signals to derive essential variables describing replication kinetics.

Major players in the artificial intelligence in the healthcare diagnosis market are directing their efforts toward the development of innovative solutions, with a focus on AI-powered disease detection. This involves leveraging artificial intelligence technologies to analyze medical data, including images, patient records, and diagnostic tests, for the identification and detection of various diseases or health conditions. For example, in May 2023, Aegis Ventures LLC, a next-generation venture studio based in the US, partnered with Northwell Holdings, a US-based medical technology company, to introduce 'Optain'. Utilizing images of the eye captured with a simple, portable retinal camera, Optain's AI not only screens for eye-related conditions but also identifies 140 diseases throughout the body. The goal is to detect these diseases at the earliest stage when they are most treatable.

In October 2022, Beckman Coulter Diagnostics, a US-based clinical diagnostics company, completed the acquisition of StoCastic LLC for an undisclosed amount. StoCastic's TriageGo is set to become the cornerstone of Beckman Coulter's AI-powered Clinical Decision Support (CDS) portfolio. This evolving discipline aims to enhance patient care by providing physicians with data-driven insights and optimizing clinical decision-making. StoCastic LLC, an artificial intelligence company based in the US, specializes in developing AI-powered tools for healthcare providers to achieve more accurate and efficient disease diagnoses.

Major companies operating in the artificial intelligence in healthcare diagnosis market include Johnson and Johnson Private Limited, Intel Corporation, International Business Machines Corporation, Medtronic, Nvidia Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., GE Healthcare, Agfa-Gevaert Group, Google Deep Mind, Babylon Health, HeartFlow Inc., Corti HQ, Aidoc, Aidoc Medical Ltd., Imagen Technologies, AliveCor Inc., Digital Diagnostics Inc., Enlitic Inc., NovaSignal Corp., Cleerly Inc., Butterfly Network Inc., IBM Watson Health, Arterys Inc., Zebra Medical Vision Inc., Vuno Inc., Riverain Technologies, CloudMedX Inc., Neural Analytics Inc.

North America was the largest region in the artificial intelligence in healthcare diagnosis market in 2024. The regions covered in the artificial intelligence in healthcare diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the artificial intelligence in healthcare diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The artificial intelligence (AI) in healthcare diagnosis market consists of revenues earned by entities by providing medical imaging analysis, genetic analysis, clinical decision support, risk prediction and stratification. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial Intelligence (AI) in the healthcare diagnosis market also includes sales of surgical robots and visual tools which are used in providing AI in healthcare diagnosis services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence in Healthcare Diagnosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence in healthcare diagnosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence in healthcare diagnosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence in healthcare diagnosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Software; Services; Hardware
  • 2) By Diagnosis: Cardiology; Oncology; Pathology; Radiology; Chest And Lung; Neurology; Other Diagnoses
  • 3) By Modality: MRI (Magnetic Resonance Imaging); CT (Computed Tomography); X-ray; Ultrasound
  • 4) By Application: In Vivo Diagnostics; In Vitro Diagnostics
  • 5) By End-User: Hospitals; Diagnostics Imaging Centers; Diagnostics Laboratories; Other End-Users
  • Subsegments:
  • 1) By Software: Diagnostic Software; Imaging Analysis Software; Predictive Analytics Software
  • 2) By Services: Consulting Services; Implementation Services; Maintenance And Support Services
  • 3) By Hardware: Diagnostic Imaging Devices; AI-Powered Medical Devices; Data Storage And Processing Hardware
  • Companies Mentioned: Johnson and Johnson Private Limited; Intel Corporation; International Business Machines Corporation; Medtronic; Nvidia Corporation; Siemens Healthcare GmbH; Koninklijke Philips N.V.; GE Healthcare; Agfa-Gevaert Group; Google Deep Mind; Babylon Health; HeartFlow Inc.; Corti HQ; Aidoc; Aidoc Medical Ltd.; Imagen Technologies; AliveCor Inc.; Digital Diagnostics Inc.; Enlitic Inc.; NovaSignal Corp.; Cleerly Inc.; Butterfly Network Inc.; IBM Watson Health; Arterys Inc.; Zebra Medical Vision Inc.; Vuno Inc.; Riverain Technologies; CloudMedX Inc.; Neural Analytics Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence in Healthcare Diagnosis Market Characteristics

3. Artificial Intelligence in Healthcare Diagnosis Market Trends And Strategies

4. Artificial Intelligence in Healthcare Diagnosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence in Healthcare Diagnosis Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Artificial Intelligence in Healthcare Diagnosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Artificial Intelligence in Healthcare Diagnosis Market Growth Rate Analysis
  • 5.4. Global Artificial Intelligence in Healthcare Diagnosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Artificial Intelligence in Healthcare Diagnosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Artificial Intelligence in Healthcare Diagnosis Total Addressable Market (TAM)

6. Artificial Intelligence in Healthcare Diagnosis Market Segmentation

  • 6.1. Global Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software
  • Services
  • Hardware
  • 6.2. Global Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiology
  • Oncology
  • Pathology
  • Radiology
  • Chest And Lung
  • Neurology
  • Other Diagnoses
  • 6.3. Global Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • MRI (Magnetic Resonance Imaging)
  • CT (Computed Tomography)
  • X-ray
  • Ultrasound
  • 6.4. Global Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • In Vivo Diagnostics
  • In Vitro Diagnostics
  • 6.5. Global Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostics Imaging Centers
  • Diagnostics Laboratories
  • Other End-Users
  • 6.6. Global Artificial Intelligence in Healthcare Diagnosis Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Software
  • Imaging Analysis Software
  • Predictive Analytics Software
  • 6.7. Global Artificial Intelligence in Healthcare Diagnosis Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consulting Services
  • Implementation Services
  • Maintenance And Support Services
  • 6.8. Global Artificial Intelligence in Healthcare Diagnosis Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Imaging Devices
  • AI-Powered Medical Devices
  • Data Storage And Processing Hardware

7. Artificial Intelligence in Healthcare Diagnosis Market Regional And Country Analysis

  • 7.1. Global Artificial Intelligence in Healthcare Diagnosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Artificial Intelligence in Healthcare Diagnosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence in Healthcare Diagnosis Market

  • 8.1. Asia-Pacific Artificial Intelligence in Healthcare Diagnosis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence in Healthcare Diagnosis Market

  • 9.1. China Artificial Intelligence in Healthcare Diagnosis Market Overview
  • 9.2. China Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence in Healthcare Diagnosis Market

  • 10.1. India Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence in Healthcare Diagnosis Market

  • 11.1. Japan Artificial Intelligence in Healthcare Diagnosis Market Overview
  • 11.2. Japan Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence in Healthcare Diagnosis Market

  • 12.1. Australia Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence in Healthcare Diagnosis Market

  • 13.1. Indonesia Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence in Healthcare Diagnosis Market

  • 14.1. South Korea Artificial Intelligence in Healthcare Diagnosis Market Overview
  • 14.2. South Korea Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence in Healthcare Diagnosis Market

  • 15.1. Western Europe Artificial Intelligence in Healthcare Diagnosis Market Overview
  • 15.2. Western Europe Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence in Healthcare Diagnosis Market

  • 16.1. UK Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence in Healthcare Diagnosis Market

  • 17.1. Germany Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence in Healthcare Diagnosis Market

  • 18.1. France Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence in Healthcare Diagnosis Market

  • 19.1. Italy Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence in Healthcare Diagnosis Market

  • 20.1. Spain Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence in Healthcare Diagnosis Market

  • 21.1. Eastern Europe Artificial Intelligence in Healthcare Diagnosis Market Overview
  • 21.2. Eastern Europe Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence in Healthcare Diagnosis Market

  • 22.1. Russia Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence in Healthcare Diagnosis Market

  • 23.1. North America Artificial Intelligence in Healthcare Diagnosis Market Overview
  • 23.2. North America Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence in Healthcare Diagnosis Market

  • 24.1. USA Artificial Intelligence in Healthcare Diagnosis Market Overview
  • 24.2. USA Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence in Healthcare Diagnosis Market

  • 25.1. Canada Artificial Intelligence in Healthcare Diagnosis Market Overview
  • 25.2. Canada Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence in Healthcare Diagnosis Market

  • 26.1. South America Artificial Intelligence in Healthcare Diagnosis Market Overview
  • 26.2. South America Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence in Healthcare Diagnosis Market

  • 27.1. Brazil Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence in Healthcare Diagnosis Market

  • 28.1. Middle East Artificial Intelligence in Healthcare Diagnosis Market Overview
  • 28.2. Middle East Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence in Healthcare Diagnosis Market

  • 29.1. Africa Artificial Intelligence in Healthcare Diagnosis Market Overview
  • 29.2. Africa Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence in Healthcare Diagnosis Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Intelligence in Healthcare Diagnosis Market Competitive Landscape
  • 30.2. Artificial Intelligence in Healthcare Diagnosis Market Company Profiles
    • 30.2.1. Johnson and Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Intel Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Medtronic Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Nvidia Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence in Healthcare Diagnosis Market Other Major And Innovative Companies

  • 31.1. Siemens Healthcare GmbH
  • 31.2. Koninklijke Philips N.V.
  • 31.3. GE Healthcare
  • 31.4. Agfa-Gevaert Group
  • 31.5. Google Deep Mind
  • 31.6. Babylon Health
  • 31.7. HeartFlow Inc.
  • 31.8. Corti HQ
  • 31.9. Aidoc
  • 31.10. Aidoc Medical Ltd.
  • 31.11. Imagen Technologies
  • 31.12. AliveCor Inc.
  • 31.13. Digital Diagnostics Inc.
  • 31.14. Enlitic Inc.
  • 31.15. NovaSignal Corp.

32. Global Artificial Intelligence in Healthcare Diagnosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence in Healthcare Diagnosis Market

34. Recent Developments In The Artificial Intelligence in Healthcare Diagnosis Market

35. Artificial Intelligence in Healthcare Diagnosis Market High Potential Countries, Segments and Strategies

  • 35.1 Artificial Intelligence in Healthcare Diagnosis Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Artificial Intelligence in Healthcare Diagnosis Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Artificial Intelligence in Healthcare Diagnosis Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer